ACS Global, Inc. (AMCY) Research

ACS Global, Inc. specializes in the acquisition, meticulous processing, and secure, long-term cryogenic storage of stem cells. The company enables individuals to privately bank their own stem cells for potential future applications in cellular therapy. Headquartered in Red Bank, New Jersey, the firm adopted its current name, ACS Global, Inc., in June 2011, having previously operated as American CryoStem Corp.

Market snapshot

Symbol
AMCY
Price
$3.00
Day change
-40.00%
Market cap
$171.3M
52-week range
3.0-3.0
Sector
Healthcare
Industry
Medical - Diagnostics & Research

Peer companies

  • Adocia S.A. (ADOCY)
  • AnGes, Inc. (AMGXF)
  • Broncus Holding Corporation (BRNHF)
  • Cell MedX Corp. (CMXC)
  • Diaceutics PLC (DIUXF)
  • EKF Diagnostics Holdings plc (EKDHF)
  • NanoRepro AG (NNGRF)
  • Planet 13 Holdings Inc. (PLNHF)

Open ACS Global, Inc. (AMCY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.